Device Trial Radar · NCT06367582
Spine Bone Cements Outcomes - Post Market Follow-up
Last checked: Nov 20, 2026Latest source record: Sep 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Sep 4, 2019
Primary completion
Sep 4, 2029
Study completion Sep 30, 2039
Sponsor
- Lead sponsor
- TeknimedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 16, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Post-Market Clinical Follow-Up (PMCF) Study to collect clinical data on safety and performance of all TEKNIMED Spine range of products: SPINEFIX, HIGH V+, OPACITY+ and F20 bone cements and mixing and injection systems, and all their private labels. TEKNIMED bone cements are legacy products, some marketed for more than 10 years. Their performance and safety have already been demonstrated by Post-Market Surveillance and previous clinical studies. The current Post-Market Clinical Follow-Up study aims to confirm these claims by collecting data in a "real-life" setting. The study is a retrospective and prospective global, single arm, non-controlled, multicentric, prospective observational study. Patients will be followed as per local standard medical care of the sites.
Conditions
- Vertebral Fracture
- Compression Fracture
- Osteoporotic Fractures
Interventions
Vertebroplasty (VP)Device
Vertebroplasty is a procedure in which a special medical-grade cement mixture is injected into a fractured vertebra to relieve pain
Kyphoplasty (KP)Device
Kyphoplasty is a procedure in which a special medical-grade cement mixture is injected into a fractured vertebra to relieve pain
Pedicular Screw Augmentation (PSA)Device
Pedicular Screw Augmentation is a procedure in which a special medical-grade cement mixture is injected into pedicular screws in order to augment fixation strength
Primary outcomes
What the sponsor says the trial is designed to measure.
- Alleviation of PainTime frame: 24 months
Locations
12 sites in 4 countries. Site status is shown where the registry gives one.
CHU HautePierre
Strasbourg, Bas-Rhin, France · Recruiting
Pôle Rachis Hôpital Privé d'Eure et Loir
Mainvilliers, Eure et Loir, France · Recruiting
Hôpital Toulouse Purpan
Toulouse, Haute Garonne, France · Recruiting
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.